Beryl Drugs Ltd

NSE: BERLDRG · BSE: 524606 · Pharmaceuticals & Biotechnology · 25 announcements

Share price: ₹25.55
Market cap: ₹12.96 Cr
Revenue (annual): ₹18.82 Cr
Net profit (annual): ₹0.42 Cr
P/E (TTM): 20.8×Sector 47.3×
Promoter holding: 27.82%+0.34% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Board Meeting Outcome 4 Board Meeting Date 4 Annual General Meeting 4 Promoter Buying 3 Other Announcement 3 Financial Results 3 Debt & Borrowing 1 Capacity Expansion 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

11 Aug 2026 17:16 IST BSE

Financial Results

Beryl Drugs Q1 FY27 Results: Net Profit ₹0.2 Cr, Down 66.7% QoQ

Beryl Drugs Ltd reported revenue from operations of ₹7.3 Cr (+52.1% YoY) and net profit of ₹0.2 Cr for Q1 FY27.

Key figure: Net profit ₹0.2 Cr

Open full results → Read the filing ↗

28 May 2026 19:05 IST BSE

Financial Results

Beryl Drugs Q4 FY26 Results: Net Profit ₹0.6 Cr, Up 200.0% YoY

Beryl Drugs Ltd reported revenue from operations of ₹5.5 Cr (+5.8% YoY) and net profit of ₹0.6 Cr (+200.0% YoY) for Q4 FY26.

Key figure: Net profit ₹0.6 Cr · +200.0% YoY

Open full results → Read the filing ↗

28 May 2026 19:05 IST BSE

Financial Results

Beryl Drugs Financial Results

Beryl Drugs reported annual revenue of ₹19.31 Crore for FY2026. The results include an unmodified audit opinion despite temporary manufacturing suspensions in the BFS section.

Value: ₹19.31 Cr

Read the filing ↗